Many COVID-19 Cost-Sharing Waivers Are Set to Expire

Although federal relief legislation tied to the pandemic required health insurers to waive cost sharing for COVID-19 testing, not treatment, many plans opted to do both anyway. In fact, a recent analysis from the Kaiser Family Foundation (KFF) found that 80% of enrollees in the individual and fully insured group insurance markets were in plans that voluntarily waived out-of-pocket costs for COVID-19 at some point during the pandemic.

Yet with the public health crisis ongoing and the race to develop and distribute an effective vaccine far from over, a considerable portion of the commercially insured population may be exposed to hefty hospital bills due to health plans’ cost-sharing waivers expiring. According to the Peterson-KFF Health System Tracker analysis, published Aug. 20, 20% of individual and fully insured group plan enrollees are in plans where a cost-sharing waiver for COVID-19 treatment has already expired, and another 16% are in plans where the waiver is scheduled to expire by the end of September.

0 Comments
© 2023 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

stars
September 22

Only Two Plans Get ‘5 out of 5’ in 2023 NCQA Ratings

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
September 22

News Briefs: CMS Says 30 States Pause Medicaid Disenrollments

READ MORE
happy-fit-seniors
September 22

CMS Administrator, AHIP Agree: Medicare Marketing Fixes Were Overdue 

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today